IRIS Accounts Production v26.1.10.61 09818597 Board of Directors 1.11.24 31.10.25 31.10.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh098185972024-10-31098185972025-10-31098185972024-11-012025-10-31098185972023-10-31098185972023-11-012024-10-31098185972024-10-3109818597ns15:EnglandWales2024-11-012025-10-3109818597ns14:PoundSterling2024-11-012025-10-3109818597ns10:Director12024-11-012025-10-3109818597ns10:PrivateLimitedCompanyLtd2024-11-012025-10-3109818597ns10:SmallEntities2024-11-012025-10-3109818597ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-3109818597ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-3109818597ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-3109818597ns10:FullAccounts2024-11-012025-10-3109818597ns10:Director22024-11-012025-10-3109818597ns10:RegisteredOffice2024-11-012025-10-3109818597ns5:CurrentFinancialInstruments2025-10-3109818597ns5:CurrentFinancialInstruments2024-10-3109818597ns5:Non-currentFinancialInstruments2025-10-3109818597ns5:Non-currentFinancialInstruments2024-10-3109818597ns5:ShareCapital2025-10-3109818597ns5:ShareCapital2024-10-3109818597ns5:RetainedEarningsAccumulatedLosses2025-10-3109818597ns5:RetainedEarningsAccumulatedLosses2024-10-3109818597ns5:PlantMachinery2024-10-3109818597ns5:MotorVehicles2024-10-3109818597ns5:ComputerEquipment2024-10-3109818597ns5:PlantMachinery2024-11-012025-10-3109818597ns5:MotorVehicles2024-11-012025-10-3109818597ns5:ComputerEquipment2024-11-012025-10-3109818597ns5:PlantMachinery2025-10-3109818597ns5:MotorVehicles2025-10-3109818597ns5:ComputerEquipment2025-10-3109818597ns5:PlantMachinery2024-10-3109818597ns5:MotorVehicles2024-10-3109818597ns5:ComputerEquipment2024-10-3109818597ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-3109818597ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-31
REGISTERED NUMBER: 09818597 (England and Wales)










A N S Medical Limited

Unaudited Financial Statements

for the Year Ended 31 October 2025






A N S Medical Limited (Registered number: 09818597)






Contents of the Financial Statements
for the Year Ended 31 October 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


A N S Medical Limited

Company Information
for the Year Ended 31 October 2025







DIRECTORS: Dr Ambu Shrivastava
Dr Naveed Shams Soomro





REGISTERED OFFICE: 84 Compton Avenue
Poole
BH14 8PY





REGISTERED NUMBER: 09818597 (England and Wales)





ACCOUNTANTS: RAA DSM Ltd
2 Heap Bridge
Bury
Lancashire
BL9 7HR

A N S Medical Limited (Registered number: 09818597)

Balance Sheet
31 October 2025

2025 2024
Notes £    £   
Fixed assets
Tangible assets 4 39,416 49,302

Current assets
Debtors 5 162,438 99,258
Cash at bank 48,796 57,175
211,234 156,433
Creditors
Amounts falling due within one year 6 (114,457 ) (111,713 )
Net current assets 96,777 44,720
Total assets less current liabilities 136,193 94,022

Creditors
Amounts falling due after more than one
year

7

(35,238

)

(42,699

)

Provisions for liabilities (9,854 ) (12,326 )
Net assets 91,101 38,997

Capital and reserves
Called up share capital 100 100
Retained earnings 91,001 38,897
91,101 38,997

A N S Medical Limited (Registered number: 09818597)

Balance Sheet - continued
31 October 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account and Statement of Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 July 2026 and were signed on its behalf by:





Dr Naveed Shams Soomro - Director


A N S Medical Limited (Registered number: 09818597)

Notes to the Financial Statements
for the Year Ended 31 October 2025

1. GENERAL INFORMATION

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
84 Compton Avenue
Poole
BH14 8PY
United Kingdom

2. ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND KEY ACCOUNTING ESTIMATES
The principal accounting policies applied in the preparation of these financial statements are set out below.These policies have been consistently applied to all the years presented, unless otherwise stated.

STATEMENT OF COMPLIANCE
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

BASIS OF PREPARATION
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

GOING CONCERN
The financial statements have been prepared on a going concern basis.

REVENUE RECOGNITION
Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax,returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

TANGIBLE ASSETS
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

DEPRECIATION
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset classDepreciation method and rate
Office equipment 25% reducing balance
Plant and machinery20% reducing balance
Motor vehicles20% reducing balance


A N S Medical Limited (Registered number: 09818597)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

2. ACCOUNTING POLICIES - continued
TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account and Statement of Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CASH AND CASH EQUIVALENTS
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

TRADE DEBTORS
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRADE CREDITORS
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

DIVIDENDS
Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

A N S Medical Limited (Registered number: 09818597)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

2. ACCOUNTING POLICIES - continued

BORROWINGS
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

LEASES
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

SHARE CAPITAL
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

DEFINED CONTRIBUTION PENSION OBLIGATION
A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

A N S Medical Limited (Registered number: 09818597)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

4. TANGIBLE FIXED ASSETS
Plant and Motor Office
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 November 2024
and 31 October 2025 3,300 61,864 1,898 67,062
DEPRECIATION
At 1 November 2024 1,948 14,435 1,377 17,760
Charge for year 270 9,486 130 9,886
At 31 October 2025 2,218 23,921 1,507 27,646
NET BOOK VALUE
At 31 October 2025 1,082 37,943 391 39,416
At 31 October 2024 1,352 47,429 521 49,302

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 23,747 25,698
Other debtors 307 307
Income tax asset 27,310 18,379
Investments 29,732 -
Directors loan account 80,920 54,457
Prepayments 422 417
162,438 99,258

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Hire purchase contracts 7,461 7,461
Trade creditors 373 -
Corporation tax 104,941 102,006
Accruals 1,682 2,246
114,457 111,713

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Hire purchase contracts 35,238 42,699